Save the date: IRLAB holds Capital Markets Day on October 17, 2023
GOTHENBURG, SE / ACCESSWIRE / September 11, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 11, 2023 - IRLAB...
Year: 2023
Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
SHENZHEN, China, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”),...
Regeneron Provides Update on Planned Chief Financial Officer Transition
Robert E. Landry to retire effective February 2024; Christopher Fenimore, long-standing Senior Vice President, Head of Accounting and Controller, to...
Regeneron Announces Updates to Board of Directors
Kathryn Guarini, Ph.D., and David P. Schenkein, M.D., join Regeneron’s Board of DirectorsTARRYTOWN, N.Y., Sept. 08, 2023 (GLOBE NEWSWIRE) --...
Werth Family Investment Associates Converts $5.8 Million of Debt into Cingulate Equity at a Premium
Conversion Follows $1.0 Million Capital Investment in August 2023KANSAS CITY, Kan., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:...
Seer to Participate in Upcoming September Investor Conferences
REDWOOD CITY, Calif., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive...
Moderna Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
CAMBRIDGE, MA / ACCESSWIRE / September 8, 2023 / Moderna, Inc. (Nasdaq:MRNA) has been notified that TRC Capital Investment Corporation...
West Island Brands Inc. Announces Change of Auditor
Toronto, Ontario--(Newsfile Corp. - September 8, 2023) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) ("West Islands" or the...
Hemogenyx Pharmaceuticals PLC Announces CBR Patent Application Update
LONDON, UK / ACCESSWIRE / September 8, 2023 / Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company") Hemogenyx Pharmaceuticals plc...
Integrated RCM Services Launches to Provide Third-Party Billing for Behavioral Health Providers
BURLINGTON, NJ / ACCESSWIRE / September 8, 2023 / The process of insurance billing, utilization review, appeals, and payment can...
Pressure BioSciences’ BaroFold Technology Achieves Pivotal Equipment Sale and Begins Scale-up in Service to Leading Global Contract Devt. & Mfg. Organization
Patented BaroFold Platform is Critical Enabler for Biopharma Manufacturing and Quality Assurance;Company Believes Future BaroFold Equipment and Recurring Utilization/Support FeesShould...
Novo Integrated Sciences Provides Update on Potential Share Repurchase Program
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today provides an update with respect to...
CENTR Launches Enhanced Gut Health and Cognitive Performance Drinks on Amazon.com
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2023) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) ("CENTR" or...
New Company, Integrated RCM Services, to Provide Third-Party Billing for Behavioral Health Providers
HAINESPORT, NJ / ACCESSWIRE / September 8, 2023 / The process of insurance billing, utilization review, appeals, and payment can...
Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test
New assays for ketamine and tramadol testing pass initial Intelligent Fingerprinting design phase and begin next stage of transfer to...
Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine
Published Phase 2 Study findings demonstrate safety and efficacy of idrevloride in hypertonic saline for treatment of primary ciliary dyskinesiaAbstract...
WW International, Inc. Announces Participation in Upcoming Investor Conferences
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced...
BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease
--Site activation allows for patients in the State of New York to participate in the BRTX-100 trial— --15 Clinical Sites...
CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology
BERKELEY HEIGHTS, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquisition Strategy Differentiates Company in Projected $51B Global Cannabis Market
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- via IBN — Lucy Scientific Discovery Inc. (NASDAQ: LSDI) today announces its placement in...